Skip to content

Metabolomics characteristics of type 2 diabetes mellitus with abnormal glycemic variability and its correlation with macrovascular disease

Metabolomics characteristics of type 2 diabetes mellitus with abnormal glycemic variability and its correlation with macrovascular disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17012706
Enrollment
Unknown
Registered
2017-09-18
Start date
2017-09-30
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

abnormal glucose fluctuation group:Nil
normal glucose fluctuation group:Nil
T2DM with macrovascular disease:Nil
T2DM without macrovascular disease:Nil

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This study included type 2 diabetes patients and the inclusive criteria listed as follows: 1. according with the 1999 World Health Organization (WHO) diabetes classification and diagnostic criteria; 2. aged 30 - 70 years old; 3. BMI within the range of 18.5~28.0 kg/m2; 4. HbA1c <10.0%;

Exclusion criteria

Exclusion criteria: The exclusion criteria of the first stage: 1. diabetic macrovascular disease (cardiovascular disease, cerebrovascular disease and peripheral arterial disease); 2. diabetic microangiopathy (including diabetic retinopathy, diabetic nephropathy and diabetic neuropathy); 3. severe liver or kidney disease; 4. infection; 5. malignant tumor; 6. severe disability, mental illness; 7. women with pregnancy or breastfeeding. The exclusion criteria of the second stage: 1. severe liver or kidney disease; 2. infection; 3. malignant tumor; 4. severe disability, mental illness; 5. women with pregnancy or breastfeeding.

Design outcomes

Primary

MeasureTime frame
metabolic profiling;

Secondary

MeasureTime frame
height;weight;blood pressure;fasting blood glucose;2-h plasma glucose;glycated hemoglobin A1c;fasting insulin;lipid;ALT;AST;urea;creatinine;uric acid;

Countries

China

Contacts

Public ContactMA XIAOJING

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

maxiaojing@sjtu.edu.cn+86 18930172032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026